Stocks and Investing Stocks and Investing
Fri, April 26, 2024

Douglas Tsao Reiterated (APLS) at Strong Buy and Held Target at $92 on, Apr 26th, 2024


Published on 2024-10-28 10:40:43 - WOPRAI, Douglas Tsao
  Print publication without navigation


Douglas Tsao of HC Wainwright & Co., Reiterated "Apellis Pharmaceuticals, Inc." (APLS) at Strong Buy and Held Target at $92 on, Apr 26th, 2024.

Douglas has made no other calls on APLS in the last 4 months.



There are 10 other peers that have a rating on APLS. Out of the 10 peers that are also analyzing APLS, 2 agree with Douglas's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Laura Chico of "Wedbush" Maintained at Hold with Decreased Target to $57 on, Wednesday, April 17th, 2024
  • Graig Suvannavejh of "Mizuho" Maintained at Hold and Held Target at $60 on, Wednesday, March 27th, 2024


These are the ratings of the 8 analyists that currently disagree with Douglas


  • Joseph Stringer of "Needham" Reiterated at Strong Buy and Held Target at $85 on, Thursday, April 25th, 2024
  • Anupam Rama of "JP Morgan" Maintained at Buy with Increased Target to $79 on, Wednesday, March 6th, 2024
  • Eliana Merle of "UBS" Maintained at Strong Buy with Increased Target to $89 on, Monday, March 4th, 2024
  • Colleen Kusy of "Baird" Reiterated at Buy and Held Target at $81 on, Tuesday, February 6th, 2024
  • Akash Tewari of "Jefferies" Upgraded from Hold to Strong Buy and Increased Target to $80 on, Monday, February 5th, 2024
  • Justin Kim of "Oppenheimer" Maintained at Buy with Increased Target to $79 on, Tuesday, January 30th, 2024
  • Steven Seedhouse of "Raymond James" Maintained at Strong Buy with Increased Target to $106 on, Thursday, January 11th, 2024
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $90 on, Tuesday, January 9th, 2024
Contributing Sources